|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Matenral thyroid cancerFrom: Kenneth J. Moise (kmoise@bcm.tmc.edu)Tue May 28 17:45:33 1996
Gary Kleinman inquired regarding the use of radioactive iodine after thyroid surgery for papillary carcinoma of the thyroid. My vote is surgery and deferral of the radioactive iodine until after delivery. This is a slow growing tumor. The studies on fetal thyroid replacement are limited to case reports. Although normal values for TFT's are available on fetal blood sampling, the frequency of sampling is unknown. I would not destroy the fetal thyroid gland. The long-term neurologic outcome of hypothyroidism in utero is unknown. Ken Moise Baylor Colleg eof Medicine
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:18:27 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.